ABMD Insider Trading Activity and SEC Form 4 Filings
ABMD insider trading summary
No open-market insider purchases or sales of Abiomed Inc (ABMD) have been reported on SEC Form 4 in the past 12 months.
Latest ABMD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 17, 2022 | Martin P Sutter | Director | Sell | $15K (48 @ $313.82) |
| Feb 17, 2022 | Martin P Sutter | Director | Sell | $370K (1,153 @ $320.61) |
| Feb 17, 2022 | Martin P Sutter | Director | Sell | $47K (147 @ $316.92) |
| Feb 17, 2022 | Martin P Sutter | Director | Sell | $108K (346 @ $311.69) |
| Feb 17, 2022 | Martin P Sutter | Director | Sell | $60K (193 @ $312.64) |
| Feb 17, 2022 | Martin P Sutter | Director | Sell | $79K (254 @ $310.65) |
| Feb 17, 2022 | Martin P Sutter | Director | Sell | $80K (260 @ $307.64) |
| Feb 17, 2022 | Martin P Sutter | Director | Sell | $102K (328 @ $309.74) |
| Feb 17, 2022 | Martin P Sutter | Director | Sell | $131K (424 @ $308.80) |
| Feb 17, 2022 | Martin P Sutter | Director | Sell | $252K (798 @ $316.02) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.